Quantbot Technologies’s Cidara Therapeutics CDTX Stock Holding History

Quantbot Technologies’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-635	Closed	-$140K	–	1752
2025 Q4	$140K	Buy	+635	New	+$103K	﹤0.01%	1337

Quantbot Technologies's CDTX Position: Q1 2026 in Review

Quantbot Technologies sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 635 shares — an estimated $140K sold.

Quantbot Technologies first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $140K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Quantbot Technologies reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Quantbot Technologies sold 635 Cidara Therapeutics shares in Q1 2026, an estimated $140K.
Quantbot Technologies first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Quantbot Technologies's Cidara Therapeutics position peaked at $140K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.